Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Current Opinion in Nephrology and Hypertension|February 22, 2019
Recent evidence for direct oral anticoagulants in chronic kidney diseaseJeffrey T Ha, Sunil V Badve, Min Jun
Internal Medicine Journal|March 27, 2024
Use of kidney failure risk equation as a tool to evaluate referrals from primary care to specialist nephrology careKatherine Li, Saiyini Pirabhahar, Max Thomsett, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 30, 2023
Kidney Function, Albuminuria, and Risk of Incident Atrial Fibrillation: A Systematic Review and Meta-AnalysisJeffrey T Ha, S Ben Freedman, Dearbhla M Kelly, et al.
NEJM Evidence|August 26, 2024
Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors in Kidney DiseaseJeffrey T Ha, Swapnil Hiremath, Min Jun, et al.
Nephrology (Carlton, Vic.)|April 2, 2026
Six-Weekly Versus Monthly Haemodialysis Blood Testing in an Australian Tertiary Kidney Service: A Quality, Safety, Green Nephrology Initiative and Cost-Saving AnalysisDaniel Hirsch, Donia George, Debbie Pugh, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 19, 2026
Sex disparities in receiving evidence-based medications in patients with CKDRui Du, Hannah Wallace, Jeffrey T Ha, et al.
Diabetes, Obesity & Metabolism|January 21, 2026
Sex differences in patterns of chronic kidney disease care in Australian primary care: A retrospective cohort study of a national general practice datasetHannah Wallace, Luke Buizen, Sunil V Badve, et al.
Kidney360|October 27, 2025
Variability in eGFR and the Risk of Adverse Kidney Outcomes and All-Cause Mortality: A Retrospective Observational Study Based on National General Practice DatasetTakaya Sasaki, Luke Buizen, Katie Harris, et al.
Annals of Internal Medicine|July 16, 2019
Benefits and Harms of Oral Anticoagulant Therapy in Chronic Kidney Disease: A Systematic Review and Meta-analysisJeffrey T Ha, Brendon L Neuen, Lap P Cheng, et al.
Diabetes, Obesity & Metabolism|July 16, 2025
Prevalence of SGLT2 inhibitor and GLP1 receptor agonist prescriptions in type 2 diabetes patients with and without chronic kidney disease: Analysis of an Australian primary care datasetHannah Wallace, James Wick, Brendon L Neuen, et al.
Pageof 2